1. Academic Validation
  2. 5-acetyl-2-arylbenzimidazoles as antiviral agents. Part 4

5-acetyl-2-arylbenzimidazoles as antiviral agents. Part 4

  • Eur J Med Chem. 2012 Jul:53:83-97. doi: 10.1016/j.ejmech.2012.03.038.
Gabriella Vitale 1 Paola Corona Mario Loriga Antonio Carta Giuseppe Paglietti Gabriele Giliberti Giuseppina Sanna Pamela Farci Maria Elena Marongiu Paolo La Colla
Affiliations

Affiliation

  • 1 Dipartimento di Scienza del Farmaco, Università degli Studi di Sassari, Via Muroni 23/a, 07100 Sassari, Italy.
Abstract

Within a project aimed at discovering new Flaviviridae inhibitors, new variously substituted 2-phenylbenzimidazoles were synthesized and evaluated in cell-based assays for cytotoxicity and Antiviral activity against viruses representatives of the three genera of the Flaviviridae family, i.e.: Pestivirus (BVDV), Flavivirus (YFV) and Hepacivirus (HCV). Title compounds were also tested against RNA viruses representative of Other single-stranded, positive-sense (ssRNA(+)) negative-sense (RNA(-)), or double-stranded (dsRNA) genomes, as well as against representatives of two DNA virus families. Nine compounds showed activity against BVDV (EC(50) = 0.8-8.0 μM), compound 31 being the most potent (EC(50) = 0.80 μM) and selective (SI = CC(50)/EC(50) = >100). When tested in an HCV replicon assay, compound 31 resulted again the most potent, displaying an EC(50) value of 1.11 μM and an SI of 100. Besides inhibiting BVDV, two compounds (35 and 38) showed a moderate activity also against YFV (EC(50) = 13 μM). Interestingly, 35 was moderately active also against RSV (EC(50) = 25 μM).

Figures